EMILY ROSE BELEN: Open Payments
NPI 1689266751 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,629 in 52 payments from 13 companies in 2025. Trend: 2023 $376 · 2024 $561 · 2025 $1,629
Food & beverage: $1,586Education: $43
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $507 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $359 |
| Amgen Inc. | 3 | $195 |
| Ardelyx, Inc. | 2 | $155 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| Lilly USA, LLC | 2 | $44 |
| Travere Therapeutics, Inc. | 7 | $43 |
| ABBVIE INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: Fabhalta, JARDIANCE, KRYSTEXXA, XPHOZAH 30 MG, AUSTEDO XR, LOKELMA, Filspari, IBSRELA.
Industry payments across CA — which companies pay providers there.
